Showing results (11-20 of 52) with videos related to

Sort By:
Pageof 6
Oncotarget|February 20, 2016
The SOX11 transcription factor is a critical regulator of basal-like breast cancer growth, invasion, and basal-like gene expressionJonathan H Shepherd, Ivan P Uray, Abhijit Mazumdar, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Insulin-like growth factor-I activates gene transcription programs strongly associated with poor breast cancer prognosisChad J Creighton, Angelo Casa, ZaWaunyka Lazard, et al.
Cancer Research|February 5, 2008
Tamoxifen resistance in breast tumors is driven by growth factor receptor signaling with repression of classic estrogen receptor genomic functionSuleiman Massarweh, C Kent Osborne, Chad J Creighton, et al.
Cancer Discovery|March 5, 2015
Intratumoral heterogeneity in a Trp53-null mouse model of human breast cancerMei Zhang, Anna Tsimelzon, Chi-Hsuan Chang, et al.
Cancer Research|September 17, 2008
Development of resistance to targeted therapies transforms the clinically associated molecular profile subtype of breast tumor xenograftsChad J Creighton, Suleiman Massarweh, Shixia Huang, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 8, 2009
Identification of novel kinase targets for the treatment of estrogen receptor-negative breast cancerCorey Speers, Anna Tsimelzon, Krystal Sexton, et al.
The Journal of Biological Chemistry|November 11, 2009
SAFB1 mediates repression of immune regulators and apoptotic genes in breast cancer cellsStephanie Hammerich-Hille, Benny A Kaipparettu, Anna Tsimelzon, et al.
Breast Cancer Research and Treatment|October 22, 2015
Androgen receptor promotes tamoxifen agonist activity by activation of EGFR in ERα-positive breast cancerAndrew Ciupek, Yassine Rechoum, Guowei Gu, et al.
Breast Cancer Research and Treatment|July 14, 2011
A gene transcription signature of obesity in breast cancerChad J Creighton, Yvonne H Sada, Yiqun Zhang, et al.
Breast Cancer Research and Treatment|October 1, 2013
Metastasis tumor-associated protein 2 enhances metastatic behavior and is associated with poor outcomes in estrogen receptor-negative breast cancerKyle R Covington, Lauren Brusco, Ines Barone, et al.
Pageof 6